Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Cullinan Oncology, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Trigilio Jeffrey (CFO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 2,340 shares
@ $9.08, valued at
$21.2k
|
|
| 06/29/2023 |
4
| AHMED NADIM (President and CEO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 759 shares
@ $11.4, valued at
$8.7k
|
|
| 06/12/2023 |
4
| Ebeling Thomas (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 18,450 options to buy
@ $13, valued at
$239.9k
|
|
| 06/12/2023 |
4
| Rosenberg Anthony (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 18,450 options to buy
@ $13, valued at
$239.9k
|
|
| 06/12/2023 |
4
| Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 18,450 options to buy
@ $13, valued at
$239.9k
|
|
| 06/12/2023 |
4
| Martin Anne-Marie (Director) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 18,450 options to buy
@ $13, valued at
$239.9k
|
|
| 06/08/2023 |
4
| Michaelson Jennifer (Chief Development Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 11,900 shares
@ $12.31, valued at
$146.5k
Sold 100 shares
@ $12.4, valued at
$1.2k
Exercised 11,900 options to buy
@ $4.3, valued at
$51.2k
Exercised 100 options to buy
@ $4.3, valued at
$430 |
|
| 05/24/2023 |
4
| AHMED NADIM (President and CEO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 707 shares
@ $9.15, valued at
$6.5k
|
|
| 05/19/2023 |
4
| Michaelson Jennifer (Chief Development Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 239 shares
@ $8.76, valued at
$2.1k
|
|
| 05/19/2023 |
4
| Jones Jeffrey Alan (Chief Medical Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 394 shares
@ $8.76, valued at
$3.5k
|
|
| 05/19/2023 |
4
| SUMER JACQUELYN L (Chief Legal Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 291 shares
@ $8.76, valued at
$2.5k
|
|
| 05/19/2023 |
4
| Trigilio Jeffrey (CFO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 399 shares
@ $8.76, valued at
$3.5k
|
|
| 05/16/2023 |
4
| Michaelson Jennifer (Chief Development Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 193 shares
@ $8.78, valued at
$1.7k
|
|
| 05/16/2023 |
4
| Trigilio Jeffrey (CFO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 347 shares
@ $8.78, valued at
$3k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Trigilio Jeffrey (CFO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 399 shares
@ $11.32, valued at
$4.5k
|
|
| 03/27/2023 |
4
| Jones Jeffrey Alan (Chief Medical Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 390 shares
@ $11.32, valued at
$4.4k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| SUMER JACQUELYN L (Chief Legal Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 305 shares
@ $11.32, valued at
$3.5k
|
|
| 03/27/2023 |
4
| AHMED NADIM (President and CEO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 706 shares
@ $10.51, valued at
$7.4k
|
|
| 02/23/2023 |
4
| AHMED NADIM (President and CEO) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 109,000 shares
@ $0
Granted 211,000 options to buy
@ $11.03, valued at
$2.3M
|
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Baeuerle Patrick (Chief Scientific Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 38,500 shares
@ $0
Granted 77,000 options to buy
@ $11.34, valued at
$873.2k
|
|
| 02/21/2023 |
4
| Michaelson Jennifer (Chief Development Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 38,500 shares
@ $0
Granted 77,000 options to buy
@ $11.34, valued at
$873.2k
|
|
| 02/21/2023 |
4
| Jones Jeffrey Alan (Chief Medical Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 60,000 shares
@ $0
Granted 120,000 options to buy
@ $11.34, valued at
$1.4M
|
|
| 01/19/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Disposed of 3,500,000 shares
@ $0
Disposed of 2,600,000 shares
@ $0
Disposed of 300,000 shares
@ $0
Acquired 350,000 options to buy
@ $0
Acquired 260,000 options to buy
@ $0
Acquired 30,000 options to buy
@ $0 |
|
|
|
|